By using cocrystal structures of PRS protein bearing either HF or our lead compound, potent PRS inhibitor T-3833261 was designed in a way that binds to the ATP site and does not bind to the proline binding site (Fig 1A). Here, WNK3 is linked to hydrops fetalis.